医药与生命科学 生命科学和制药公司面临的风险比以往任何时候都要复杂。从知识产权保护到药品定价、研究经费的减少、税收改革、供应链挑战和关税等领域问题,都对生命科学和制药公司的业务开展造成了影响。我们了解风险,并基于风险为您制定解决方案,最大限度地提高您的成功机率,同时我们还为您配备了一支既适合您的情况又符合公司文化的多学科专业团队。 我们与药品制造商、生命科学公司、医疗设备制造商、生物技术公司和合同研发组织(CRO)合作,满怀信心地面对未来。 在当前日新月异的的环境中,一位值得信赖的顾问不仅能提供相关行业洞见,还能基于战略的眼光,将成熟的专业知识和实践经验相结合以提升您的业务价值。 Survey April 17, 2025 3 min read Healthcare risk insights As healthcare leaders assessed the challenges and risks facing their organizations in the short term, managing cyber threats, rising labor costs, and third-party risks were reported as their top concerns. Other issues that rank in the top ten include workforce challenges, such as talent and labor availability and the ability to attract and retain top talent,... Read more What we do Our services Insights Leadership Our services Our experts provide industry-specific solutions tailored to your organization’s unique needs in the following areas: Pro Briefcase Technology Strategy and Operations and Software Services While primarily focused on R&D activities and funding clinical trials, commercialization requires companies to focus on IT systems and infrastructure to ensure they can support the mature and meet demand. We help companies develop and implement a road map for success. Pro Building office Supply Chain and Operations Solutions The pandemic has put broad pressure on the global supply chain due to both an overwhelming demand for select supplies, as well as reduced workforce availability and global trade challenges. We help our clients build resiliency into their operations. Pro Document Consent Cybersecurity and Privacy Services As more systems move to virtual environments, the risk of cyber threats and liabilities grows. We help build a comprehensive cybersecurity strategy to protect intellectual property, clinical trial data, employee data and patient information from theft or misuse. Pro Document Folder Public Company Transformation Services Making the leap from an R&D-focused organization to a commercial organization requires the right combination of resources, processes and technology. We support a commercial launch and also scale to support organizational growth with our proven PCT and SOX programs. Featured insights and client stories SURVEY Healthcare risk insights 3 min read As healthcare leaders assessed the challenges and risks facing their organizations in the short term, managing cyber threats, rising labor costs, and third-party risks were reported as their top concerns. Other issues that rank in the top ten include... WHITEPAPER AI in Healthcare: Navigating the Future with Governance and Innovation 18 min read The role of artificial intelligence (AI), which includes both machine learning (ML) and generative AI (GenAI), is becoming increasingly prominent in the business world. AI is challenging traditional models of business operations with its potential to... WHITEPAPER Top Compliance Priorities for U.S. Healthcare Organizations in 2025 2 min read Protiviti’s risk and compliance experts weigh in on the top compliance priorities for healthcare organizations in 2025 and what these changes mean under a new administration.Providers, payers, and life sciences organizations must refine their... CLIENT STORY A Healthcare Giant's Journey to Evaluate Risk, Strengthen Data Use Licensing Agreements with Third-Party Vendors 6 min read Organisations should regularly monitor obligations and compliance within their third-party contract universe. CLIENT STORY Leading Biotechnology Company Enhances AWS Environment Security and Risk Control 4 min read A leading biotechnology company that develops life-transforming medicines has worked for decades to improve the lives of those who rely on their work. But recently, they found themselves in need of assistance to enhance the security of their AWS... Previous Article Pagination Next Article Leadership Richard Williams Richard is a founding member and Protiviti’s Global Healthcare Practice Leader. He has extensive experience providing operational, financial, and regulatory consulting and internal audit services to the healthcare industry. In addition to leading numerous business ... Learn More Gareth Gruffydd Gareth is a Managing Director in our Southern California Internal Audit & Financial Advisory (IAFA) practice and global segment leader for Protiviti’s Pharmaceutical and Life Science practice. He has 20+ years of experience spanning various risk management ... Learn More